Evidence map›Paper›PMID 40836058›Full record

ArticleScientific reports2025

Prediction of CD8

Jia Mai, Ling Yang, YuXin Chen, XiaoXu Zeng, HongJian Xie, XiaoJuan Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jia MaiDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, No. 20, Section 3, Ren Min Nan Lu, Chengdu, 610041, Sichuan, China.
Ling YangDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, No. 20, Section 3, Ren Min Nan Lu, Chengdu, 610041, Sichuan, China.
YuXin ChenDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, No. 20, Section 3, Ren Min Nan Lu, Chengdu, 610041, Sichuan, China.
XiaoXu ZengDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, No. 20, Section 3, Ren Min Nan Lu, Chengdu, 610041, Sichuan, China.
HongJian XieDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, No. 20, Section 3, Ren Min Nan Lu, Chengdu, 610041, Sichuan, China. gonxhjyy@live.cn.
XiaoJuan LiuDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan University; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, No. 20, Section 3, Ren Min Nan Lu, Chengdu, 610041, Sichuan, China. maggielxj1979@163.com.

Funding

Horizontal Science and Technology Project of Sichuan University 23H0221Horizontal Science and Technology Project of Sichuan University 23H0222National Natural Science Foundation of China 82301923Sichuan Provincial Key Research and Development Projects 2024YFFK0268
6 · The paper itself

Abstract

The tumor microenvironment (TME), particularly CD8

Indexed as

Carcinoma, Ovarian EpithelialCD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingOvarian NeoplasmsTumor MicroenvironmentAdultAgedFemaleHumansMiddle AgedPrognosisRetrospective StudiesCD8+ T cellsHigh-grade serous ovarian cancerPeripheral blood parametersPrognosisSpatial distributionTumor microenvironment

Identifiers

PMID40836058
PMCPMC12368186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.